TUXEDO-4 - phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases
Favorite
Share
More Options
9

Open in WPS to view all 9 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
